Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes far beyond the readOnly/openWorld/idempotent annotations by disclosing fan-out behavior across SEC, XBRL, USPTO, USAspending, FDA, DOL, GDELT, and GLEIF. It also explains soft-failure for the USPTO sunset, that empty sections mean genuine 'no data', and that private companies produce resolved:false rather than a bare error.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but there is no output schema, so the extensive enumeration of return sections and source behaviors earns its place. It is front-loaded with purpose, examples, and the preference directive before diving into return details.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Without an output schema, the description compensates fully by enumerating every return field (cik, company_name, resolved_from/resolved_to, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used/sources_failed) and key edge cases. An agent can anticipate output shape, failure modes, and expected empty sections.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description adds useful meaning: it gives concrete examples (ticker 'AAPL', zero-padded CIK '0000320193', name 'Moderna'), explains that names resolve via SEC EDGAR company-name match, and describes the resolved:false/notes behavior for private companies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a clear verb and resource: it produces a 'full cross-source profile of a US public company' and anchors that with natural-language queries like 'Tell me about X' and 'company profile for Microsoft.' It explicitly contrasts with chaining single-pack SEC/XBRL/news lookups, distinguishing it from simpler sibling tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly directs the agent: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also clarifies when it will not resolve a company (private entities return resolved:false with notes) and notes that person/place support is not yet available.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Many tools have overlapping purposes, e.g., ask_pipeworx, ask_pipeworx_grounded, deep_research, entity_profile, and compare_entities all retrieve factual data about entities. Additionally, multiple polymarket tools (bet_research, polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) are highly specialized but can be confused without careful reading of descriptions.

Naming Consistency1/5

Naming conventions are highly inconsistent: snake_case (ai_visibility_check, generate_llms_txt), lowercase phrases (ask_pipeworx, forget, recall), and mixed styles (entity_profile, scan_competitor_ai_presence). No clear pattern like verb_noun; tools like 'remember' and 'forget' are single words while others are lengthy phrases.

Tool Count3/5

32 tools is on the high side for a single server, but the coverage is broad (data retrieval, prediction markets, Finnish registry, memory, utilities). However, many tools are redundant or overly specialized, making the count feel bloated. A more focused set could be 20-25 tools.

Completeness3/5

The Pipeworx tools provide deep coverage for factual data retrieval, and the Finnish registry has basic operations. However, there are gaps in other areas, and the set lacks a unified domain. The inclusion of memory tools and a random llms.txt generator feels out of place, breaking the coherence.